Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT00099489 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen